The first generic drug maker to launch after a patent expires captures up to 90% of the market - and holds onto it for years. Here's why being first matters more than price, and how companies win big.
The first generic drug maker to launch after a patent expires captures up to 90% of the market - and holds onto it for years. Here's why being first matters more than price, and how companies win big.